Cargando…
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
Eukaryotic elongation factor 2 kinase (eEF-2K), through its phosphorylation of elongation factor 2 (eEF2), provides a mechanism by which cells can control the rate of the elongation phase of protein synthesis. The activity of eEF-2K is increased in rapidly proliferating malignant cells, is inhibited...
Autores principales: | Tekedereli, Ibrahim, Alpay, S. Neslihan, Tavares, Clint D. J., Cobanoglu, Zehra E., Kaoud, Tamer S., Sahin, Ibrahim, Sood, Anil K., Lopez-Berestein, Gabriel, Dalby, Kevin N., Ozpolat, Bulent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401164/ https://www.ncbi.nlm.nih.gov/pubmed/22911754 http://dx.doi.org/10.1371/journal.pone.0041171 |
Ejemplares similares
-
Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2013) -
PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells
por: Ozpolat, Bulent, et al.
Publicado: (2012) -
STAMP2 increases oxidative stress and is critical for prostate cancer
por: Jin, Yang, et al.
Publicado: (2015) -
Down-Regulation of 5-HT(1B) and 5-HT(1D) Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells
por: Gurbuz, Nilgun, et al.
Publicado: (2014) -
Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion
por: Ashour, Ahmed A, et al.
Publicado: (2014)